Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Health Serv Res ; 58(5): 1056-1065, 2023 10.
Artigo em Inglês | MEDLINE | ID: mdl-36734605

RESUMO

OBJECTIVE: To quantify shared patient relationships between primary care physicians (PCPs) and cardiologists and oncologists and the degree to which those relationships were captured within insurance networks. DATA SOURCES: Secondary analysis of Vericred data on physician networks, CareSet data on physicians' shared Medicare patients, and insurance plan attributes from Health Insurance Compare. Data validation exercises used data from Physician Compare and IQVIA. STUDY DESIGN: Cross-sectional study of the PCP-to-specialist in-network shared patient percentage (primary outcome). We also categorized networks by insurance market segment (Medicare Advantage [MA], Medicaid managed care, small-group or individually purchased), insurance plan type, and network breadth. DATA EXTRACTION: We analyzed data on 219,982 PCPs, 29,400 cardiologists, and 22,745 oncologists who, in 2021, accepted MA (n = 941 networks), Medicaid managed care (n = 293), and individually-purchased (n = 332) and small-group (n = 501) plans. PRINCIPAL FINDINGS: Networks captured, on average, 64.6% of PCP-cardiology shared patient ties, and 61.8% of PCP-oncologist ties. Less than half of in-network ties (44.5% and 38.9%, respectively) were among physicians with a common organizational affiliation. After adjustment for network breadth, we found no evidence of differences in the shared patient percentage across insurance market segments or networks of different types (p-value >0.05 for all comparisons). An exception was among national versus local and regional networks, where we found that national plans captured fewer shared patient ties, particularly among the narrowest networks (58.4% for national networksvs. 64.7% for local and regional networks for PCP-cardiology). CONCLUSIONS: Given recent trends toward narrower networks, our findings underscore the importance of incorporating additional and nuanced measures of network composition to aid plan selection (for patients) and to guide regulatory oversight.


Assuntos
Medicare Part C , Médicos , Idoso , Humanos , Estados Unidos , Estudos Transversais , Seguro Saúde , Relações Médico-Paciente
2.
AMIA Annu Symp Proc ; 2020: 707-716, 2020.
Artigo em Inglês | MEDLINE | ID: mdl-33936445

RESUMO

Efforts to enhance Electronic Health Record (EHR) data for the study of conditions in which social and economic variables play a prominent role include linking clinical data to sources of external information via patient-specific geocodes. This approach is convenient, but whether geographic-area-level information from secondary sources is adequate as a surrogate of individual-level information is not fully understood. We used Behavioral Risk Factor Surveillance System (BRFSS) epidemiologic data to compare associations of individual income, median aggregate income, and Area Deprivation Index (ADI)-a validated score of U.S. socioeconomic deprivation-with various health outcomes. Median income and ADI assigned according to respondent area of residence were significantly associated with various health outcomes, but with substantially lower effect sizes than those of individual income. Our results show the limited ability of median income and ADI at the level of metropolitan/micropolitan statistical areas versus individual income for use as measures of socioeconomic status.


Assuntos
Sistema de Vigilância de Fator de Risco Comportamental , Classe Social , Adulto , Humanos , Renda , Pessoa de Meia-Idade
3.
J Allergy Clin Immunol Pract ; 7(8): 2535-2543, 2019.
Artigo em Inglês | MEDLINE | ID: mdl-31706485

RESUMO

Mobile health and web applications (apps), wearables, and other personal monitoring devices have tremendous potential to improve the management of asthma. More than 500 asthma-related apps, whether standalone or paired with sensors on inhalers, are currently available for health education, symptom recording, tracking of inhaler use, displaying environmental alerts, and providing medication reminders. Benefits of these tools include the ability to longitudinally collect symptom, trigger, and inhaler usage data, allowing the detection of significant changes over time to help patients and their caregivers determine whether symptoms are worsening. In addition, data from external information sources, including weather, allergen, and air quality reports, can be integrated with user-specific data to enhance predictions on when patients may experience symptoms and/or need to avoid triggers. Barriers to adoption of asthma-related apps and inhaler-based devices include uncertain efficacy and effectiveness, potential high cost, sustained user engagement, and concerns about privacy. Moreover, ensuring the acceptability and utility of asthma management apps for individuals of all races/ethnicities, socioeconomic groups, ages, genders, and literacy levels is necessary. Based on studies thus far, mobile health apps and inhaler-based devices have great potential to serve as useful tools in the patient-doctor relationship and revolutionize asthma care.


Assuntos
Asma/diagnóstico , Monitorização Fisiológica/estatística & dados numéricos , Telemedicina/estatística & dados numéricos , Asma/epidemiologia , Asma/terapia , Acessibilidade aos Serviços de Saúde , Humanos , Aplicativos Móveis , Nebulizadores e Vaporizadores , Educação de Pacientes como Assunto , Estados Unidos/epidemiologia
4.
Ann Fam Med ; 17(4): 363-366, 2019 07.
Artigo em Inglês | MEDLINE | ID: mdl-31285214

RESUMO

Primary care access in Medicaid improved after the Patient Protection and Affordable Care Act despite millions of new beneficiaries. One possible explanation is that practices are scheduling more appointments with advanced practitioners. To test this theory, we used data from a secret shopper study in which callers simulated new Medicaid patients and requested appointments with 3,742 randomly selected primary care practices in 10 states. Conditional on scheduling an appointment, simulated patients asked whether the practitioner was a physician or advanced practitioner. From 2012 through 2016, the proportion of appointments scheduled with advanced practitioners increased from 7.7% to 12.9% (P <.001) across the 10 states.


Assuntos
Prática Avançada de Enfermagem/estatística & dados numéricos , Agendamento de Consultas , Medicaid/estatística & dados numéricos , Atenção Primária à Saúde/organização & administração , Humanos , Patient Protection and Affordable Care Act , Estados Unidos
5.
J Neurosurg Spine ; : 1-9, 2019 Jan 25.
Artigo em Inglês | MEDLINE | ID: mdl-30684933

RESUMO

OBJECTIVEEnhanced recovery after surgery (ERAS) protocols address pre-, peri-, and postoperative factors of a patient's surgical journey. The authors sought to assess the effects of a novel ERAS protocol on clinical outcomes for patients undergoing elective spine or peripheral nerve surgery.METHODSThe authors conducted a prospective cohort analysis comparing clinical outcomes of patients undergoing elective spine or peripheral nerve surgery after implementation of the ERAS protocol compared to a historical control cohort in a tertiary care academic medical center. Patients in the historical cohort (September-December 2016) underwent traditional surgical care. Patients in the intervention group (April-June 2017) were enrolled in a unique ERAS protocol created by the Department of Neurosurgery at the University of Pennsylvania. Primary objectives were as follows: opioid and nonopioid pain medication consumption, need for opioid use at 1 month postoperatively, and patient-reported pain scores. Secondary objectives were as follows: mobilization and ambulation status, Foley catheter use, need for straight catheterization, length of stay, need for ICU admission, discharge status, and readmission within 30 days.RESULTSA total of 201 patients underwent surgical care via an ERAS protocol and were compared to a total of 74 patients undergoing traditional perioperative care (control group). The 2 groups were similar in baseline demographics. Intravenous opioid medications postoperatively via patient-controlled analgesia was nearly eliminated in the ERAS group (0.5% vs 54.1%, p < 0.001). This change was not associated with an increase in the average or daily pain scores in the ERAS group. At 1 month following surgery, a smaller proportion of patients in the ERAS group were using opioids (38.8% vs 52.7%, p = 0.041). The ERAS group demonstrated greater mobilization on postoperative day 0 (53.4% vs 17.1%, p < 0.001) and postoperative day 1 (84.1% vs 45.7%, p < 0.001) compared to the control group. Postoperative Foley use was decreased in the ERAS group (20.4% vs 47.3%, p < 0.001) without an increase in the rate of straight catheterization (8.1% vs 11.9%, p = 0.51).CONCLUSIONSImplementation of this novel ERAS pathway safely reduces patients' postoperative opioid requirements during hospitalization and 1 month postoperatively. ERAS results in improved postoperative mobilization and ambulation.

SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...